Note: This bulletin is replaced by NC Health Choice Move to Medicaid: Timeline for Claims Adjudication and Process for Prior Approvals.
Blog Entry List
Effective with date of service Nov. 15, 2022, Medicaid and NC Health Choice cover Eflapegrastim-xnst injection, for subcutaneous use (Rolvedon).
Effective with date of service Oct. 19, 2022, Medicaid and NC Health Choice cover Sodium Thiosulfate injection, for intravenous use (Pedmark).
Effective with date of service Oct. 3, 2022, Medicaid and NC Health Choice cover Ranibizumab-eqrn injection, (Cimerli)
Indigotindisulfonate Sodium Injection, for Intravenous Use (Bludigo™) HCPCS Code: Billing Guidelines
Effective with date of service Sept 30, 2022, Medicaid and NC Health Choice cover Indigotindisulfonate sodium injection (Bludigo)
Effective with date of service Oct. 5, 2022, Medicaid and NC Health Choice cover Bevacizumab-maly injection (Alymsys)
Effective with date of service August 31, 2022, Medicaid and NC Health Choice cover Pfizer-BioNTech COVID-19 Vaccine
Effective with date of service Aug. 31, 2022, Medicaid and NC Health Choice programs cover Moderna COVID-19 Vaccine
Effective Oct. 1, 2022, Pluvicto must be billed with HCPCS code A9607
Updated HCPCS Code, unit of coverage and maximum reimbursement rate
Effective Oct. 1, 2022, Medicaid and NC Health Choice cover Albuterol Sulfate inhalation solution (0.021%, 0.042% and 0.083%)
Effective Oct. 1, 2022, Medicaid and NC Health Choice cover Ipratropium Bromide inhalation solution, 0.02%
Effective Oct. 1, 2022, Medicaid and NC Health Choice cover Ipratropium Bromide/Albuterol Sulfate inhalation solution
Effective Sept. 15, 2022, Medicaid and NC Health Choice cover Olipudase alfa-rpcp for injection, for intravenous use
Effective Oct. 1, 2022, Medicaid and NC Health Choice cover Levalbuterol Hydrochloride inhalation solution (Xopenex)